Published in Gastric Cancer on January 01, 2006
Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer (2009) 4.04
Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer (2011) 2.18
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer (2012) 2.09
Risk factors for metachronous gastric cancer in the remnant stomach after early cancer surgery. World J Surg (2010) 1.76
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer (2011) 1.58
Entirely laparoscopic radical gastrectomy for adenocarcinoma: lymph node yield and resection margins. Surg Endosc (2008) 1.51
Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer (2012) 1.33
Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey. World J Surg (2010) 1.32
Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today (2010) 1.15
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer (2010) 1.13
Progression of remnant gastric cancer is associated with duration of follow-up following distal gastrectomy. World J Gastroenterol (2012) 1.12
The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc (2013) 1.10
Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes. Surg Endosc (2013) 1.07
Laparoscopy-assisted combined resection for synchronous gastric and colorectal cancer: report of three cases. Surg Today (2009) 1.05
Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer (2014) 1.03
Recent results of therapy for scirrhous gastric cancer. Surg Today (2009) 0.96
Signet-ring cell carcinoma of the esophagus associated with Barrett's epithelium: report of a case. Surg Today (2007) 0.94
Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer. Gastric Cancer (2011) 0.93
Impact of intraoperative blood loss on survival after curative resection for gastric cancer. World J Gastroenterol (2013) 0.92
Functional outcomes by reconstruction technique following laparoscopic proximal gastrectomy for gastric cancer: double tract versus jejunal interposition. World J Surg Oncol (2014) 0.91
Magnifying endoscopy in upper gastroenterology for assessing lesions before completing endoscopic removal. World J Gastroenterol (2012) 0.90
The Early Experience of Laparoscopy-assisted Gastrectomy for Gastric Cancer at a Low-volume Center. J Gastric Cancer (2010) 0.90
Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis. World J Surg (2012) 0.90
Validation of staging systems for gastric cancer. Gastric Cancer (2008) 0.90
Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this? World J Gastroenterol (2014) 0.90
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol (2014) 0.88
VEGF is a target molecule for peritoneal metastasis and malignant ascites in gastric cancer: prognostic significance of VEGF in ascites and efficacy of anti-VEGF monoclonal antibody. Onco Targets Ther (2013) 0.87
Gastric cancer: Current status of lymph node dissection. World J Gastroenterol (2016) 0.87
Current role of minimally invasive approaches in the treatment of early gastric cancer. World J Gastroenterol (2014) 0.85
Risk factors of developing interval early gastric cancer after negative endoscopy. Dig Dis Sci (2014) 0.84
Incidence of metachronous gastric cancer in the remnant stomach after synchronous multiple cancer surgery. Gastric Cancer (2013) 0.84
Prognostic factors for stage IV gastric cancer. Int Surg (2013) 0.83
Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. Gastric Cancer (2013) 0.82
Is Laparoscopic Surgery the Standard of Care for GI Luminal Cancer? Indian J Surg (2014) 0.82
Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients. Mol Cancer (2009) 0.82
Newly emerging standard chemotherapies for gastric cancer and clinical potential in elderly patients. World J Gastrointest Oncol (2009) 0.81
Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer. Surg Today (2014) 0.81
Influence of excess body weight on the surgical outcomes of total gastrectomy. Surg Today (2011) 0.81
Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis. Br J Cancer (2009) 0.81
Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol (2014) 0.81
Laparoscopy-assisted subtotal gastrectomy with very small remnant stomach: a novel surgical procedure for selected early gastric cancer in the upper stomach. Gastric Cancer (2011) 0.80
Clinicopathological and prognostic significance of CD24 overexpression in patients with gastric cancer: a meta-analysis. PLoS One (2014) 0.80
Photodynamic therapy using nanoparticle loaded with indocyanine green for experimental peritoneal dissemination of gastric cancer. Cancer Sci (2014) 0.80
Additional gastrectomy after endoscopic submucosal dissection for early gastric cancer patients with comorbidities. Int J Surg Oncol (2012) 0.80
Correlation between the length of the pyloric cuff and postoperative evaluation after pylorus-preserving gastrectomy. Gastric Cancer (2010) 0.79
Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion. Surg Endosc (2013) 0.79
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-. Radiat Oncol (2014) 0.79
Can an intramucosal undifferentiated-type gastric cancer become a candidate for endoscopic submucosal resection? Gastric Cancer (2009) 0.78
Laparoscopic gastric cancer surgery: Current evidence and future perspectives. World J Gastroenterol (2016) 0.78
Clinical significance of the anterosuperior lymph nodes along the common hepatic artery identified by sentinel node mapping in patients with gastric cancer. Gastric Cancer (2015) 0.78
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational study. J Cancer Res Clin Oncol (2014) 0.78
Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosis. Br J Cancer (2015) 0.78
Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells. PLoS One (2015) 0.78
Oncologic outcome with use of sodium hyaluronate-carboxymethylcellulose barrier in gastric cancer. Int Surg (2013) 0.77
Subtotal gastrectomy for gastric cancer. World J Gastroenterol (2014) 0.77
Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance. Gastric Cancer (2008) 0.77
Potential role of aquaporin 3 in gastric intestinal metaplasia. Oncotarget (2015) 0.77
Endoscopic features of early-stage signet-ring-cell carcinoma of the stomach. World J Gastrointest Endosc (2015) 0.77
Survival benefit of traditional chinese herbal medicine (a herbal formula for invigorating spleen) in gastric cancer patients with peritoneal metastasis. Evid Based Complement Alternat Med (2014) 0.77
Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway. Oncol Rep (2014) 0.77
Improving outcome for scirrhous gastric cancer. Gastric Cancer (2009) 0.77
A pilot study evaluating the safety and toxicity of epirubicin, cisplatin, and UFT (ECU regimen) in advanced gastric carcinoma. J Gastrointest Oncol (2011) 0.77
Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation. Sci Rep (2016) 0.76
Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol (2016) 0.75
Intra-Abdominal Complications after Curative Gastrectomies Worsen Prognoses of Patients with Stage II-III Gastric Cancer. Yonago Acta Med (2016) 0.75
Evaluation of the recurrence pattern of gastric cancer after laparoscopic gastrectomy with D2 lymphadenectomy. Springerplus (2016) 0.75
Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis. BMC Cancer (2017) 0.75
Diagnosis and therapies for gastric non-invasive neoplasia. World J Gastroenterol (2015) 0.75
A GSDMB enhancer-driven HSV thymidine kinase-expressing vector for controlling occult peritoneal dissemination of gastric cancer cells. BMC Cancer (2015) 0.75
Authors' reply: should we inherit bursectomy or discard it? Gastric Cancer (2011) 0.75
The evaluation of surgical treatment for gastric cancer patients with noncurative resection. Langenbecks Arch Surg (2012) 0.75
Surgical and Survival Outcome Following Truly Palliative Gastrectomy in Patients with Incurable Gastric Cancer. World J Surg (2016) 0.75
Kidney metastasis of resected early gastric carcinoma: report of a case. Surg Today (2007) 0.75
Use of Body Mass Index to Predict the Prognosis of Patients with Remnant Gastric Cancer. Yonago Acta Med (2017) 0.75
Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer (1998) 16.63
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med (2007) 12.62
D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med (2008) 9.00
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol (2011) 6.53
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol (2009) 5.56
Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501. J Clin Oncol (2004) 4.31
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet (2008) 2.89
Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol (2006) 2.73
Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery (2013) 2.43
Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc Natl Acad Sci U S A (2007) 2.30
Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer (2011) 2.18
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection: a critical reappraisal from the viewpoint of lymph node retrieval. J Am Coll Surg (2004) 2.18
Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer (2012) 2.09
Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer (2002) 2.01
Forty-three cases of obturator hernia. Am J Surg (2004) 1.98
Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol (2008) 1.93
Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer (2002) 1.74
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res (2012) 1.74
DNA polymerase theta is preferentially expressed in lymphoid tissues and upregulated in human cancers. Int J Cancer (2004) 1.72
Middle pancreatectomy: safety and long-term results. Surgery (2009) 1.69
A semidwarf phenotype of barley uzu results from a nucleotide substitution in the gene encoding a putative brassinosteroid receptor. Plant Physiol (2003) 1.63
Treatment of early gastric cancer in the elderly patient: results of EMR and gastrectomy at a national referral center in Japan. Gastrointest Endosc (2005) 1.60
Pancreaticoduodenectomy for advanced gastric cancer. Gastric Cancer (2005) 1.53
Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. J Gastroenterol (2004) 1.52
Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas. Pancreas (2011) 1.52
Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation. Transplantation (2011) 1.47
Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol (2007) 1.46
Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR. World J Surg (2010) 1.41
Inflammatory fibroid polyps of the stomach and Helicobacter pylori. J Gastroenterol Hepatol (2004) 1.40
Cleistogamous flowering in barley arises from the suppression of microRNA-guided HvAP2 mRNA cleavage. Proc Natl Acad Sci U S A (2009) 1.38
Identification of silencing of nine genes in human gastric cancers. Cancer Res (2002) 1.37
Lysyl oxidase is a tumor suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res (2004) 1.35
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer. J Gastroenterol (2009) 1.34
Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg (2011) 1.33
Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer (2009) 1.33
Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol (2007) 1.33
Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest (2007) 1.32
Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey. World J Surg (2010) 1.32
Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg (2011) 1.28
Longterm outcomes of early-stage gastric carcinoma patients treated with laparoscopy-assisted surgery. J Am Coll Surg (2007) 1.26
Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery (2006) 1.25
CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus. Clin Cancer Res (2006) 1.23
Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples. Cancer Sci (2008) 1.23
Gastric cancer with metastasis to the gingiva. J Gastroenterol Hepatol (2004) 1.23
Paclitaxel chemotherapy for the treatment of gastric cancer. Gastric Cancer (2009) 1.22
Survival after curative resection for mucinous adenocarcinoma of the colorectum. Dis Colon Rectum (2003) 1.22
Single-institute prospective trial of laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma. Gastric Cancer (2011) 1.22
Laparoscopy-assisted distal gastrectomy with systemic lymph node dissection for early gastric carcinoma: a review of 43 cases. J Am Coll Surg (2003) 1.21
Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res (2007) 1.21
A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912). Jpn J Clin Oncol (2012) 1.20
Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol (2006) 1.19
Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann Surg Oncol (2008) 1.19
Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int J Cancer (2009) 1.18
Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol (2013) 1.18
A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer. Gastroenterology (2010) 1.17
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Ann Surg (2017) 1.16
Recurrence in jejunal pouch after proximal gastrectomy for early upper gastric cancer. Gastric Cancer (2003) 1.14
Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci (2004) 1.14
Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol (2006) 1.14
Afferent loop obstruction after distal gastrectomy with Roux-en-Y reconstruction. World J Surg (2010) 1.13
Artificial neural network for prediction of lymph node metastases in gastric cancer: a phase II diagnostic study. Ann Surg Oncol (2004) 1.13
Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer (2007) 1.13
Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg (2012) 1.13
Prolonged Toll-like receptor stimulation leads to down-regulation of IRAK-4 protein. J Leukoc Biol (2004) 1.11
Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery? Pancreas (2009) 1.11
Peppermint oil reduces gastric spasm during upper endoscopy: a randomized, double-blind, double-dummy controlled trial. Gastrointest Endosc (2003) 1.11
Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice. Cancer Res (2005) 1.10
Follow-up of gastric cancer: a review. Gastric Cancer (2006) 1.10
Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci (2003) 1.09
TNM and Japanese staging systems for gastric cancer: how do they coexist? Gastric Cancer (2004) 1.09
Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? Limited to Siewert type II, yes. Ann Surg (2015) 1.09
E-cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer. Int J Cancer (2002) 1.09
Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer. Cancer Immunol Immunother (2006) 1.09
Oncological problems in pancreatic cancer surgery. World J Gastroenterol (2006) 1.08
Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol (2011) 1.08
Surgical treatment of early gastric cancer. Dig Surg (2007) 1.08
Billroth 1 versus Roux-en-Y reconstructions: a quality-of-life survey at 5 years. Int J Clin Oncol (2007) 1.07
Field studies on the regulation of abscisic acid content and germinability during grain development of barley: molecular and chemical analysis of pre-harvest sprouting. J Exp Bot (2006) 1.06
Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer (2009) 1.06
Inflammatory myofibroblastic tumor (IMT) of the pancreas. J Hepatobiliary Pancreat Surg (2002) 1.06